Vaccine-elicited SIV and HIV envelope-specific IgA and IgG memory B cells in rhesus macaque peripheral blood correlate with functional antibody responses and reduced viremia

Vaccine

Volumn 29, Issue 17, 2011, Pages 3310-3319

  Brocca Cofano, Egidio ^a   McKinnon, Katherine ^a   Demberg, Thorsten ^a   Venzon, David ^a   Hidajat, Rachmat ^a   Xiao, Peng ^a   Daltabuit Test, Mara ^a   Patterson, L Jean ^a   Robert Guroff, Marjorie ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Memory B cells; Replication competent adenovirus recombinant; Rhesus macaque; Simian immunodeficiency virus; Vaccine

Indexed keywords

CD40 LIGAND; CPG OLIGODEOXYNUCLEOTIDE; GLYCOPROTEIN GP 140; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTERLEUKIN 21; POLYCLONAL ANTIBODY; RECOMBINANT VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY DEPENDENT CELL MEDIATED VIRAL INHIBITION; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; B LYMPHOCYTE DIFFERENTIATION; CHRONIC DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFICACY; ENZYME LINKED IMMUNOSPOT ASSAY; FLOW CYTOMETRY; HUMAN IMMUNODEFICIENCY VIRUS; LYMPHOCYTE PROLIFERATION; MEMORY CELL; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMA CELL; PRIORITY JOURNAL; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; TRANSCYTOSIS; VACCINATION; VIREMIA; VIRUS ENVELOPE; VIRUS RECOMBINANT;

ANIMALS; B-LYMPHOCYTES; ENZYME-LINKED IMMUNOSPOT ASSAY; FLOW CYTOMETRY; HIV; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOLOGIC MEMORY; MACACA MULATTA; SIMIAN IMMUNODEFICIENCY VIRUS; VIRAL ENVELOPE PROTEINS; VIREMIA;

EID: 79954627394     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.02.066     Document Type: Article

References (47)

1. McHeyzer-Williams L.J., McHeyzer-Williams M.G. Antigen-specific memory B cell development. Annu Rev Immunol 2005, 23:487-513.
2. McHeyzer-Williams L.J., McHeyzer-Williams M.G. Memory B cell evolution: B cell biology. Adv Exp Med Biol 2007, 596:31-45.
3. Amanna I.J., Carlson N.E., Slifka M.K. Duration of humoral immunity to common viral and vaccine antigens. N Engl J Med 2007, 357:1903-1915.
4. Radbruch A., Muehlinghaus G., Luger E.O., Inamine A., Smith K.G., Dorner T., et al. Competence and competition: the challenge of becoming a long-lived plasma cell. Nat Rev Immunol 2006, 6:741-750.
5. Dorner T., Radbruch A. Antibodies and B cell memory in viral immunity. Immunity 2007, 27:384-392.
6. Lanzavecchia A., Sallusto F. Human B cell memory. Curr Opin Immunol 2009, 21:298-304.
7. Tangye S.G., Tarlinton D.M. Memory B cells: effectors of long-lived immune responses. Eur J Immunol 2009, 39:2065-2075.
8. Crotty S., Felgner P., Davies H., Glidewell J., Villarreal L., Ahmed R. Cutting edge: long-term B cell memory in humans after smallpox vaccination. J Immunol 2003, 171:4969-4973.
9. Vinuesa C.G., Tangye S.G., Moser G., Mackay C.R. Follicular B helper T cells in antibody responses and autoimmunity. Nat Rev Immunol 2005, 5:853-865.
10. Crotty S., Aubert R.D., Glidewell J., Ahmed R. Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system. J Immunol Methods 2004, 286:111-122.
11. Bonsignori M., Moody M.A., Parks R.J., Holl T.M., Kelsoe G., Hicks C.B., et al. HIV-1 envelope induces memory B cell responses that correlate with plasma antibody levels after envelope gp120 protein vaccination or HIV-1 infection. J Immunol 2009, 183:2708-2717.
12. Guan Y., Sajadi M.M., Kamin-Lewis R., Fouts T.R., Dimitrov A., Zhang Z., et al. Discordant memory B cell and circulating anti-Env antibody responses in HIV-1 infection. Proc Natl Acad Sci USA 2009, 106:3952-3957.
13. Ahlers J.D., Belyakov I.M. Strategies for optimizing targeting and delivery of mucosal HIV vaccines. Eur J Immunol 2009, 39:57-69.
14. Pinna D., Corti D., Jarrossay D., Sallusto F., Lanzavecchia A. Clonal dissection of the human memory B-cell repertoire following infection and vaccination. Eur J Immunol 2009, 39:1260-1270.
15. Takahashi Y. Memory B cells in systemic and mucosal immune response: implications for successful vaccination. Biosci Biotechnol Biochem 2007, 71:2358-2366.
16. Lubeck M.D., Natuk R., Myagkikh M., Kalyan N., Aldrich K., Sinangil F., et al. Long-term protection of chimpanzees against high-dose HIV-1 challenge induced by immunization. Nat Med 1997, 3:651-658.
17. Patterson L.J., Beal J., Demberg T., Florese R.H., Malkevich N., Venzon D., et al. Replicating adenovirus HIV/SIV recombinant priming alone or in combination with a gp140 protein boost results in significant control of viremia following a SHIV89.6P challenge in Mamu-A*01 negative rhesus macaques. Virology 2008, 374:322-337.
18. Bogers W.M.J.M., Davis D., Baak I., Kan E., Hofman S., Sun Y., et al. Systemic neutralizing antibodies induced by long interval mucosally primed systemically boosted immunization correlate with protection from mucosal SHIV challenge. Virology 2008, 382:217-225.
19. Patterson L.J., Malkevitch N., Venzon D., Pinczewski J., Gómez-Román V.R., Wang L., et al. Protection against mucosal simian immunodeficiency virus SIV(mac251) challenge by using replicating adenovirus-SIV multigene vaccine priming and subunit boosting. J Virol 2004, 78:2212-2221.
20. Malkevitch N.V., Patterson L.J., Aldrich M.K., Wu Y., Venzon D., Florese R.H., et al. Durable protection of rhesus macaques immunized with a replicating adenovirus-SIV multigene prime/protein boost vaccine regimen against a second SIVmac251 rectal challenge: role of SIV-specific CD8+ T cell responses. Virology 2006, 353:83-98.
21. Gómez-Román V.R., Patterson L.J., Venzon D., Liewehr D., Aldrich K., Florese R., et al. Vaccine-elicited antibodies mediate antibody-dependent cellular cytotoxicity correlated with significantly reduced acute viremia in rhesus macaques challenged with SIVmac251. J Immunol 2005, 174:2185-2189.
22. Gómez-Romón V.R., Florese R.H., Peng B., Montefiori D., Kalyanaraman V.S., Venzon D., et al. An adenovirus-based HIV subtype B prime/boost vaccine regimen elicits antibodies mediating broad antibody-dependent cellular cytotoxicity against non-subtype B HIV strains. J Acquir Immune Defic Syndr 2006, 43:270-277.
23. Hidajat R., Xiao P., Zhou Q., Venzon D., Summers L.E., Kalyanaraman V.S., et al. Correlation of vaccine-elicited systemic and mucosal nonneutralizing antibody activities with reduced acute viremia following intrarectal simian immunodeficiency virus SIVmac251 challenge of rhesus macaques. J Virol 2009, 83:791-801.
24. Florese R.H., Demberg T., Xiao P., Kuller L., Larsen K., Summers L.E., et al. Contribution of nonneutralizing vaccine-elicited antibody activities to improved protective efficacy in rhesus macaques immunized with Tat/Env compared with multigenic vaccines. J Immunol 2009, 182:3718-3727.
25. Xiao P., Zhao J., Patterson L.J., Brocca-Cofano E., Venzon D., Kozlowski P.A., et al. Multiple vaccine-elicited nonneutralizing antienvelope antibody activities contribute to protective efficacy by reducing both acute and chronic viremia following simian/human immunodeficiency virus SHIV89.6P challenge in rhesus macaques. J Virol 2010, 84:7161-7173.
26. Bernasconi N.L., Traggiai E., Lanzavecchia A. Maintenance of serological memory by polyclonal activation of human memory B cells. Science 2002, 298:2199-2202.
27. Douagi I., Forsell M.N.E., Sundling C. Influence of novel CD4 binding-defective HIV-1 envelope glycoprotein immunogens on neutralizing antibody and T-cell responses in nonhuman primates. J Virol 2010, 84:1683-1695.
28. Kuhrt D., Faith S., Hattemer A., Leone A., Sodora D., Picker L., et al. Naïve and memory B cells in the rhesus macaque can be differentiated by surface expression of CD27 and have differential responses to CD40 ligation. J Immunol Methods 2011, 363:166-176.
29. Zhou Q., Hidajat R., Peng B., Venzon D., Aldrich M.K., Richardson E., et al. Comparative evaluation of oral and intranasal priming with replication-competent adenovirus 5 host range mutant (Ad5hr)-simian immunodeficiency virus (SIV) recombinant vaccines on immunogenicity and protective efficacy against SIV(mac251). Vaccine 2007, 25:8021-8035.
30. Peng S.L. Signaling in B cells via Toll-like receptors. Curr Opin Immunol 2005, 17:230-236.
31. Ettinger R., Sims G.P., Fairhurst A.M., Robbins R., da Silva Y.S., Spolski R., et al. IL-21 induces differentiation of human naive and memory B cells into antibody-secreting plasma cells. J Immunol 2005, 175:7867-7879.
32. Sanz I., Wei C., Lee F.E., Anolik J. Phenotypic and functional heterogeneity of human memory B cells. Semin Immunol 2008, 20:67-82.
33. Shi Y., Agematsu K., Ochs H.D., Sugane K. Functional analysis of human memory B-cell subpopulations: IgD+CD27+ B cells are crucial in secondary immune response by producing high affinity IgM. Clin Immunol 2003, 108:28-37.
34. Agematsu K., Nagumo H., Yang F.C., Nakazawa T., Fukushima K., Ito S., et al. B cell subpopulations separated by CD27 and crucial collaboration of CD27+ B cells and helper T cells in immunoglobulin production. Eur J Immunol 1997, 27:2073-2079.
35. Shokrgozar M.A., Sam M.R., Amirkhani A., Shokri F. Frequency analysis of HBsAg-specific B lymphocytes in high-responder individuals to recombinant hepatitis B vaccine: comparison of LDA and ELISPOT assays. Scand J Immunol 2006, 64:536-543.
36. Blink E.J., Light A., Kallies A., Nutt S.L., Hodgkin P.D., Tarlinton D.M. Early appearance of germinal center-derived memory B cells and plasma cells in blood after primary immunization. J Exp Med 2005, 201:545-554.
37. Manz R.A., Lohning M., Cassese G., Thiel A., Radbruch A. Survival of long-lived plasma cells is independent of antigen. Int Immunol 1998, 10:1703-1711.
38. Blanchard-Rohner G., Pulickal A.S., Jol-van der Zijde C.M., Snape M.D., Pollard A.J. Appearance of peripheral blood plasma cells and memory B-cells in a primary and secondary immune response in humans. Blood 2009, 114:4998-5002.
39. Malaspina A., Moir S., DiPoto A.C., Ho J., Wang W., Roby G., et al. CpG oligonucleotides enhance proliferative and effector responses of B Cells in HIV-infected individuals. J Immunol 2008, 181:1199-1206.
40. Jiang W., Lederman M.M., Harding C.V., Rodriguez B., Mohner R.J., Sieg S.F. TLR9 stimulation drives naive B cells to proliferate and to attain enhanced antigen presenting function. Eur J Immunol 2007, 37:2205-2213.
41. Good K.L., Avery D.T., Tangye S.G. Resting human memory B cells are intrinsically programmed for enhanced survival and responsiveness to diverse stimuli compared to naive B cells. J Immunol 2009, 182:890-901.
42. Agematsu K., Hokibara S., Nagumo H., Komiyama A. CD27: a memory B-cell marker. Immunol Today 2000, 21:204-206.
43. Klein U., Rajewsky K., Kuppers R. Human immunoglobulin (Ig)M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J Exp Med 1998, 188:1679-1689.
44. Fecteau J.F., Cote G., Neron S. A new memory CD27-IgG+ B cell population in peripheral blood expressing VH genes with low frequency of somatic mutation. J Immunol 2006, 177:3728-3736.
45. Wirths S., Lanzavecchia A. ABCB1 transporter discriminates human resting naive B cells from cycling transitional and memory B cells. Eur J Immunol 2005, 35:3433-3441.
46. Fecteau J.F., Roy A., Neron S. Peripheral blood CD27+ IgG+ B cells rapidly proliferate and differentiate into immunoglobulin-secreting cells after exposure to low CD154 interaction. Immunology 2009, 128:e353-e365.
47. Bohnhorst J.O., Thoen J.E., Natvig J.B., Thompson K.M. Significantly depressed percentage of CD27+ (memory) B cells among peripheral blood B cells in patients with primary Sjogren's syndrome. Scand J Immunol 2001, 54:421-427.